Idexx Laboratories Inc., the maker of diagnostics tests for animals, fell the most in more than 14 months in New York after disclosing an investigation by the Federal Trade Commission to determine whether it competed unfairly. The company said on a conference call that the Federal Trade Commission is looking into whether Idexx is engaging in unfair competition. Idexx said it was cooperating with the FTC and confident of its compliance with antitrust laws. Idexx fell $5.48, or 9.5 percent, to $52.49 ON jAN. 29, 2010 in Nasdaq Stock Market composite trading, for its biggest decline since November 2008.

If you are a current shareholder and/or purchased during the period between Nov. 4, 2008 and Jan. 29, 2010 and would like to discuss your options of exercising your rights as a shareholder, please contact us.

Please submit the following information so we can determine if you qualify for the suit. If you don't know all the specific details, partial information is also acceptable.